Your browser doesn't support javascript.
loading
(+)-corynoline Regulates the Proliferation,Stemness and Apoptosis of Triple Negative Breast Cancer Cells / 中国医学科学院学报
Acta Academiae Medicinae Sinicae ; (6): 244-252, 2022.
Artículo en Chino | WPRIM | ID: wpr-927872
ABSTRACT
Objective To explore the performance and mechanism of(+)-corynoline in treating triple negative breast cancer MDA-MB-436 cells and thus provide an option for the development of drugs against this cancer. Methods The viability,proliferation,apoptosis and migration/invasion of MDA-MB-436 cells treated with(+)-corynoline were detected by CCK-8 assay,colony formation assay,flow cytometry and Transwell assay,respectively.Furthermore,Western blotting was employed to determine the expression of related proteins,and RNA-Seq was performed for the MDA-MB-436 cells treated with(+)-corynoline. Results (+)-corynoline inhibited the proliferation and stemness and promoted the apoptosis of MDA-MB-436 cells.Further,(+)-corynoline may activate the oxidative phosphorylation pathway to play a role in inhibiting triple negative breast cancer. Conclusion (+)-corynoline can inhibit triple negative breast cancer cells,which helps to address the poor efficacy of existing chemotherapeutics and facilitate the development of drugs against this cancer.
Asunto(s)

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Alcaloides de Berberina / Neoplasias de la Mama / Movimiento Celular / Apoptosis / Línea Celular Tumoral / Proliferación Celular / Neoplasias de la Mama Triple Negativas Límite: Femenino / Humanos Idioma: Chino Revista: Acta Academiae Medicinae Sinicae Año: 2022 Tipo del documento: Artículo

Similares

MEDLINE

...
LILACS

LIS

Texto completo: Disponible Índice: WPRIM (Pacífico Occidental) Asunto principal: Alcaloides de Berberina / Neoplasias de la Mama / Movimiento Celular / Apoptosis / Línea Celular Tumoral / Proliferación Celular / Neoplasias de la Mama Triple Negativas Límite: Femenino / Humanos Idioma: Chino Revista: Acta Academiae Medicinae Sinicae Año: 2022 Tipo del documento: Artículo